This study will include children and adolescents between the ages of 6 to 17 years old and examines the effectiveness, safety, and tolerability of an investigational medication versus a placebo over the course of a 12-week period. Patients' clinical response in this study will be monitored by weekly visits with a child psychiatrist, in part using rating scales from parent and teacher to measure clinical response. If at any time during the study the parent or clinician feels it is not within the child's best interest to continue in the study, the patient will be removed from the study and offered alternative treatment. Investigators will be working closely with parents and teachers to ascertain medication effects. Note- Study participation and research evaluations are provided at no charge to eligible subjects.
Participation is always voluntary and can be terminated at any time.